Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- PART I International Provision of Public Goods under a Globalized Intellectual Property Regime
- PART II Innovation and Technology Transfer in a Protectionist Environment
- PART III Sectoral Issues: Essential Medicines and Traditional Knowledge
- PART IV Reform and Regulation Issues
- 22 Issues Posed by a World Patent System
- 23 Intellectual Property Arbitrage: How Foreign Rules Can Affect Domestic Protections
- 24 An Agenda for Radical Intellectual Property Reform
- Comment: Whose Rules, Whose Needs? Balancing Public and Private Interests
- 25 Diffusion and Distribution: The Impacts on Poor Countries of Technological Enforcement within the Biotechnology Sector
- 26 Equitable Sharing of Benefits from Biodiversity-Based Innovation: Some Reflections under the Shadow of a Neem Tree
- 27 The Critical Role of Competition Law in Preserving Public Goods in Conflict with Intellectual Property Rights
- 28 Expansionist Intellectual Property Protection and Reductionist Competition Rules: A TRIPS Perspective
- 29 Can Antitrust Policy Protect the Global Commons from the Excesses of IPRs?
- Comment I: Competition Law as a Means of Containing Intellectual Property Rights
- 30 “Minimal” Standards for Patent-Related Antitrust Law under TRIPS
- Comment II: Competitive Baselines for Intellectual Property Systems
- 31 WTO Dispute Settlement: Of Sovereign Interests, Private Rights, and Public Goods
- 32 The Economics of International Trade Agreements and Dispute Settlement with Intellectual Property Rights
- 33 Intellectual Property Rights and Dispute Settlement in the World Trade Organization
- 34 WTO Dispute Resolution and the Preservation of the Public Domain of Science under International Law
- 35 Recognizing Public Goods in WTO Dispute Settlement: Who Participates? Who Decides? The Case of TRIPS and Pharmaceutical Patents Protection
- Index
25 - Diffusion and Distribution: The Impacts on Poor Countries of Technological Enforcement within the Biotechnology Sector
Published online by Cambridge University Press: 05 May 2010
- Frontmatter
- Contents
- List of contributors
- Preface
- PART I International Provision of Public Goods under a Globalized Intellectual Property Regime
- PART II Innovation and Technology Transfer in a Protectionist Environment
- PART III Sectoral Issues: Essential Medicines and Traditional Knowledge
- PART IV Reform and Regulation Issues
- 22 Issues Posed by a World Patent System
- 23 Intellectual Property Arbitrage: How Foreign Rules Can Affect Domestic Protections
- 24 An Agenda for Radical Intellectual Property Reform
- Comment: Whose Rules, Whose Needs? Balancing Public and Private Interests
- 25 Diffusion and Distribution: The Impacts on Poor Countries of Technological Enforcement within the Biotechnology Sector
- 26 Equitable Sharing of Benefits from Biodiversity-Based Innovation: Some Reflections under the Shadow of a Neem Tree
- 27 The Critical Role of Competition Law in Preserving Public Goods in Conflict with Intellectual Property Rights
- 28 Expansionist Intellectual Property Protection and Reductionist Competition Rules: A TRIPS Perspective
- 29 Can Antitrust Policy Protect the Global Commons from the Excesses of IPRs?
- Comment I: Competition Law as a Means of Containing Intellectual Property Rights
- 30 “Minimal” Standards for Patent-Related Antitrust Law under TRIPS
- Comment II: Competitive Baselines for Intellectual Property Systems
- 31 WTO Dispute Settlement: Of Sovereign Interests, Private Rights, and Public Goods
- 32 The Economics of International Trade Agreements and Dispute Settlement with Intellectual Property Rights
- 33 Intellectual Property Rights and Dispute Settlement in the World Trade Organization
- 34 WTO Dispute Resolution and the Preservation of the Public Domain of Science under International Law
- 35 Recognizing Public Goods in WTO Dispute Settlement: Who Participates? Who Decides? The Case of TRIPS and Pharmaceutical Patents Protection
- Index
Summary
ABSTRACT
Technological enforcement of proprietary rights in biotechnological innovations will result in uniformly and universally enforced rights in those innovations. These rights should generate enhanced returns to innovation, but at the cost of reduced rates of diffusion. The study estimates the impacts of technological enforcement on different states, depending on their initial conditions, and finds that those countries on the technological frontier will gain most, while those furthest from the frontier must wait many years to receive any benefits whatsoever. Technological enforcement will generate additional benefits but at the cost of a regressive impact on world benefit distribution.
Introduction
This chapter considers the impacts of biotechnological changes that are likely to eliminate the need for the domestic application of intellectual property rights (IPRs) laws within the agricultural sector. New technologies will soon render it feasible to sell biological organisms (such as seeds and plants) that are unable to be reproduced by the purchaser. This innovation, once applied universally, will render unnecessary the domestic enforcement of seed patent legislation and plant variety protection. Then the restrictions on use inherent within those laws will be enforced technologically rather than legally, and these will have uniform impact on purchasers across the world. Technological enforcement will generate a globally uniform and universally enforceable system of proprietary rights.
What will be the impact of this movement away from a world of IPRs and toward a world of technologically enforced rights in innovations?
- Type
- Chapter
- Information
- International Public Goods and Transfer of Technology Under a Globalized Intellectual Property Regime , pp. 669 - 694Publisher: Cambridge University PressPrint publication year: 2005
- 4
- Cited by